High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: Implications for diabetic retinopathy

Current Eye Research

Volumn 36, Issue 8, 2011, Pages 747-753

  Chronopoulos, Argyrios ^a   Trudeau, Kyle ^a   Roy, Sumon ^a   Huang, Hu ^b   Vinores, Stanley A ^b   Roy, Sayon ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Basement membrane; Diabetic retinopathy; High glucose; Vascular permeability

Indexed keywords

COLLAGEN TYPE 4; DEXTRAN; FIBRONECTIN; GLUCOSE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; IN VITRO STUDY; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA CELL; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BASEMENT MEMBRANE; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELLS, CULTURED; COLLAGEN TYPE IV; DEXTRANS; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBRONECTINS; FLUORESCEIN-5-ISOTHIOCYANATE; GLUCOSE; RATS; RETINAL VESSELS; SWEETENING AGENTS; TIGHT JUNCTIONS; UP-REGULATION;

EID: 79960731769     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.585735     Document Type: Article

References (38)

1. Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest. 1968;47:1973-1999.
2. Merimee TJ, Siperstein MD, Fineberg SE, McKusick VA. The microangiopathic lesions of diabetes mellitus: An evaluation of possible causative factors. Trans Assoc Am Physicians. 1970;83:102-112.
3. Tsilibary EC: Microvascular basement membranes in diabetes mellitus. J Pathol. 2003;200:537-546 (Pubitemid 36818254)
4. Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes. 1994;43:441-446. (Pubitemid 24064253)
5. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, Sado Y, Huang ZS, Nesburn AB, Kenney MC. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996;44:1469-1479.
6. Walton HA, Byrne J, Robinson GB. Studies of the permeation properties of glomerular basement membrane: Cross-linking renders glomerular basement membrane permeable to protein. Biochim Biophys Acta. 1992;1138:173-183.
7. Boyd-White J, Williams JC, Jr. Effect of cross-linking on matrix permeability. A model for AGE-modifed basement membranes. Diabetes. 1996;45:348-353. (Pubitemid 26069050)
8. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47:1953-1959. (Pubitemid 28549205)
9. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol. 2004;36:1206-1237. (Pubitemid 38519069)
10. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galac-tosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res. 1993;57:723-735. (Pubitemid 24039476)
11. Vinores SA, Derevjanik NL, Mahlow J, Berkowitz BA, Wilson CA. Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: com parison with magnetic resonance imaging. Pathol Res Pract. 1998;194:497-505. (Pubitemid 28393714)
12. Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ, Schlingemann RO. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Exp Eye Res. 2009;89:4-15.
13. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci. 1996;37:258-266. (Pubitemid 26057051)
14. Roy S, Maiello M, Lorenzi M. Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest. 1994;93:438-442. (Pubitemid 24030866)
15. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fbronectin induced by diabetes or high glucose: Phenomenon with a memory. Proc Natl Acad Sci USA. 1990;87:404-408.
16. Nishikawa T, Giardino I, Edelstein D, Brownlee M. Changes in diabetic retinal matrix protein m RNA levels in a common transgenic mouse strain. Curr Eye Res. 2000;21:581-587.
17. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes. 1991;40:102-110.
18. Oshitari T, Polewski P, Chadda M, Li AF, Sato T, Roy S. Effect of combined antisense oligonucleotides against high-glucose-and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes. 2006;55:86-92. (Pubitemid 43343302)
19. Roy S, Ha J, Trudeau K, Beglova E. Vascular basement membrane thickening in diabetic retinopathy. Curr Eye Res. 2010;35:1045-1056.
20. Williamson JR, Vogler NJ, Kilo C. Estimation of vascular basement membrane thickness. Theoretical and practical considerations. Diabetes. 1969;18:567-578.
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354. (Pubitemid 9256559)
22. O'Donnell ME, Brandt JD, Curry FR. Na-K-Cl cotrans-port regulates intracellular volume and monolayer permeability of trabecular meshwork cells. Am J Physiol. 1995;268:C1067-1074.
23. Perkins TW, Alvarado JA, Polansky JR, Stilwell L, Maglio M, Juster R. Trabecular meshwork cells grown on flters. Conductivity and cytochalasin effects. Invest Ophthalmol Vis Sci. 1988;29:1836-1846. (Pubitemid 19015071)
24. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outfow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037. (Pubitemid 32289800)
25. Man S, Ubogu EE, Williams KA, Tucky B, Callahan MK, Ransohoff RM. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol. 2008;2008:384982.
26. Nooteboom A, Hendriks T, Otteholler I, van der Linden CJ. Permeability characteristics of human endothelial mono-layers seeded on different extracellular matrix proteins. Mediators Infamm. 2000;9:235-241. (Pubitemid 32055502)
27. Izumi T, Shibata Y, Yamamoto T. Quick-freeze, deep-etch studies of endothelial components, with special reference to cytoskeletons and vesicle structures. J Electron Microscopy Technique. 1991;19:316-326.
28. Elgjo RF, Henriksen T, Evensen SA. Ultrastructural identifca-tion of umbilical cord vein endothelium in situ and in culture. Cell Tiss Res. 1975;162:49-59.
29. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. Ultrastructural localization of vascular permeability factor/ vascular endothelial growth factor (VPF/VEGF) to the albu-minal plasma membrane and vesiculo-vacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem. 1995;43:381-389.
30. Vinores SA, Sen H, Campochiaro PA. An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sci 1992;33:1870-1878.
31. Luna JD, Chan C-C, Derevjanik NL, Mahlow J, Chiu C, Peng B, Tobe T, Campochiaro PA, Vinores SA. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: Comparison with vascular endothelial growth factor, tumor necrosis factor α, and interleukin-1β-mediated breakdown. J Neurosci Res. 1997;49:268-280. (Pubitemid 27344187)
32. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for infammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452. (Pubitemid 39561611)
33. Engerman R, Bloodworth JM, Jr., Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes. 1977;26:760-769. (Pubitemid 8174116)
34. Hammes HP. Pericytes and the pathogenesis of diabetic retin-opathy. Horm Metab Res. 2005;37 (Suppl. 1):39-43.
35. Hayden MR, Sowers JR, Tyagi SC. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: The matrix preloaded. Cardiovasc Diabetol. 2005;4:9.
36. Roy S, Sato T, Paryani G, Kao R. Downregulation of fbronec-tin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes. 2003;52:1229-1234. (Pubitemid 36523361)
37. Cherian S, Roy S, Pinheiro A. Tight glycemic control regulates fbronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci. 2009;50:943-949.
38. Fisher RF. The deformation matrix theory of basement membrane: A study of water fow through elastic and rigid fla-ments in the rat. J Physiol. 1988;406:1-14.